Apellis Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Welcome, everyone, to the 41st Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior analysts here at JPMorgan. I'm joined by my team, Malcolm Kono, and Priyanka Grover. Our next presenting company is Apellis. And presenting on behalf of the company, we have CEO, Cedric Francois. Cedric?
Thank you very much. thank you for inviting us. So good to do this in person again. So in the next 20 minutes, I'm going to take you through the story around that pennies what we have been doing in the recent past and what we have to look forward to in the next year.
These are our forward-looking statements. You can also find our SEC filings online. So we have a lot to look forward to. The next month, we have our PDUFA and geographic atrophy on February 26 and with the opportunity to deliver the first ever treatment for geographic atrophy, one of the leading causes of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |